http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3468535-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_279ab70f4d019762a94da59436a74fc2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2017-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fa6a2dbd27f0401f038bd609d78c55d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17fecd13d494e7a4114ea591039e7a90
publicationDate 2019-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3468535-A1
titleOfInvention Resveratrol solubilisation product for pharmaceutical purposes
abstract The invention relates to a solubilisation product consisting of resveratrol, polysorbate 80 and polysorbate 20 as well as at least one medium-chain triglyceride and tocopherol for use as a pharmaceutical product. The solubilisation product can be used as pharmaceutical product in the treatment of Alzheimer's disease, Friedreich's ataxia, lysosomal diseases, in particular Tay-Sachs disease, cancer, diabetes, atherosclerosis, heart diseases, arthritis and/or autoimmune diseases.
priorityDate 2016-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395968
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226490425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227155105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406142
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359

Total number of triples: 51.